患者血液管理市場：製品、コンポーネント、エンドユーザー別-2025-2030年の世界予測

患者血液管理市場は、2023年に158億5,000万米ドルと評価され、2024年には171億米ドルに達すると予測され、CAGR 8.00％で成長し、2030年には271億7,000万米ドルになると予測されています。

患者血液管理（PBM）は、輸血を必要とする可能性のある患者のケアを最適化するための、集学的でエビデンスに基づいたアプローチです。PBMの範囲には、個々の患者のニーズに合わせた具体的な戦略を通じて、不必要な輸血を減らし、出血を最小限に抑え、患者の転帰を改善することが含まれます。このアプローチは、血液供給不足、輸血関連合併症、ヘルスケア環境におけるコスト抑制という課題に対処するために不可欠です。PBMは、外科、腫瘍学、外傷治療、慢性疾患管理など様々な医療分野で応用されており、病院、診療所、血液銀行が主要なエンドユーザーとなっています。市場の成長には、慢性疾患や外科疾患の有病率の上昇、輸血のリスクに関する意識の高まり、細胞救済や代用血液などの技術の進歩が影響しています。PBMの実施を奨励する規制の枠組みは、市場拡大にさらに拍車をかける。血液保存を強化し、データ収集を自動化し、個別化医療を可能にする技術に投資することで、市場の好機をつかむことができます。非侵襲的ヘモグロビン・モニタリングや新しい赤血球造血刺激因子製剤の開発も機会をもたらします。しかし、導入コストの高さ、認識不足、従来の輸血慣行からの逸脱に対する消極性といった課題が、市場の成長を阻害しています。研究開発と技術革新は、費用対効果の高いPBMソリューションの開発と、認知度と採用率を高めるための教育プログラムに重点を置くことができます。PBM導入後の患者の転帰を分析することで、有効性と安全性に関する貴重なデータを提供し、より多くのヘルスケアプロバイダーを惹きつけることができます。PBM市場の性質はダイナミックで、技術の進歩や規制の変更に後押しされています。この情勢をうまく乗り切るには、利害関係者が新たな動向を常に把握し、協力関係を育み、血液の誤用や希少性の課題に積極的に取り組み、患者のケアと安全性を高めながらビジネスの成長を確保する必要があります。

市場力学：急速に進化する患者血液管理市場の主要市場インサイトを公開

患者血液管理市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 血液疾患の急増に伴う交通事故の増加による血液管理の必要性
  • 様々な患者血液管理ガイドラインの入手可能性
  • 献血を奨励する政府の取り組み
• 市場抑制要因
  • 自動化システムの高コスト
• 市場機会
  • 患者血液管理における技術の進歩
  • 先進的な血液保存・輸血デバイスの開発
• 市場の課題
  • 医療従事者の不足

ポーターの5つの力：患者血液管理市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：患者血液管理市場における外部からの影響の把握

外部マクロ環境要因は、患者血液管理市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析患者血液管理市場における競合情勢の把握

患者血液管理市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス患者血液管理市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、患者血液管理市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨患者血液管理市場における成功への道筋を描く

患者血液管理市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 血液疾患の蔓延による交通事故の増加による血液管理の必要性
    • さまざまな患者血液管理ガイドラインの利用可能性
    • 献血を奨励する政府の取り組み
  • 抑制要因
    • 自動化システムの高コスト
  • 機会
    • 患者血液管理における技術の進歩
    • 先進的な血液保存・輸血機器の開発
  • 課題
    • 医療従事者の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 患者血液管理市場：製品別

• アクセサリー
  • 血液バッグ
  • 注射器と針
  • バイアル＆チューブ
• 機器
  • 血液培養検査装置
    • 自動血液培養システム
    • 実験装置のサポート
  • 血液処理装置
    • 血液細胞処理装置
    • 遠心分離機
  • 血液貯蔵装置
    • 医療用冷凍庫
    • 医療用冷蔵庫
  • 輸血装置
    • アフェレーシス装置
    • 細胞救済システム
    • プラズマおよびプラズマ成分分離装置
  • 診断および検査機器
    • 血液型分析装置
    • 血液分析装置
    • NGSプラットフォーム
    • PCR装置
• 試薬とキット
  • アッセイキット
  • 血液培養培地
  • 血液型判定試薬
  • スライド染色試薬
• ソフトウェア
  • 血液銀行管理ソフトウェア
  • 輸血管理ソフトウェア

第7章 患者血液管理市場：コンポーネント別

• プラズマ
• 全血と赤血球

第8章 患者血液管理市場：エンドユーザー別

• 血液銀行
• 診断クリニックと病理学研究室
• 病院

第9章 南北アメリカの患者血液管理市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の患者血液管理市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの患者血液管理市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Asahi Kasei Medical Co. Ltd.
• B. Braun Melsungen AG
• Bio-Rad Laboratories, Inc.
• Biomerieux SA
• Danaher Corporation
• F. Hoffmann-La Roche LTD.
• Fresenius Se & Co. KGaA
• Grifols, S.A.
• Haemonetics Corporation
• Immucor, Inc.
• LivaNova, Inc.
• Macopharma, Inc.
• Merck & Co., Inc.
• Terumo Corporation

LIST OF FIGURES

• FIGURE 1. PATIENT BLOOD MANAGEMENT MARKET RESEARCH PROCESS
• FIGURE 2. PATIENT BLOOD MANAGEMENT MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PATIENT BLOOD MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PATIENT BLOOD MANAGEMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PATIENT BLOOD MANAGEMENT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PATIENT BLOOD MANAGEMENT MARKET DYNAMICS
• TABLE 7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SYRINGE & NEEDLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY VIAL & TUBE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY AUTOMATED BLOOD CULTURE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SUPPORTING LABORATORY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CELL PROCESSOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL FREEZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL REFRIGERATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APHERESIS MACHINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CELL SALVAGE SYSTEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA & PLASMA COMPONENT SEPARATOR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD GROUPING ANALYZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMATOLOGY ANALYZER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY NGS PLATFORM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PCR INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ASSAY KIT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TYPING REAGENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SLIDE STAINING REAGENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY TRANSFUSION MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY WHOLE BLOOD & RED BLOOD CELL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 51. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 53. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CLINIC & PATHOLOGY LAB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 54. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 59. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 60. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 61. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 62. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 63. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 64. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 65. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 66. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 68. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 70. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 71. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 72. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 73. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 74. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 75. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 76. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 77. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 78. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 79. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 82. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 83. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 84. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 85. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 86. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 87. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 88. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 89. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 90. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 91. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 94. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 95. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 96. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 97. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 98. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 99. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 100. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 101. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 102. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 103. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 104. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 106. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 107. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 108. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 109. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 110. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 111. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 112. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 113. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 114. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 115. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 118. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 119. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 120. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 121. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 122. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 123. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 124. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 125. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 126. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 127. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 129. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 131. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 132. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 133. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 134. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 136. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 137. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 138. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 139. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 140. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 141. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 142. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 144. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 145. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 146. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 147. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 148. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 149. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 150. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 151. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 152. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 153. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 154. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 156. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 157. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 158. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 159. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 160. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 161. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 162. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 163. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 164. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 165. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 166. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 168. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 169. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 170. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 171. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 172. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 173. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 174. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 175. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 176. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 177. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 180. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 181. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 182. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 183. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 184. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 185. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 186. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 187. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 188. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 189. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 190. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 192. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 193. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 194. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 195. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 196. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 197. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 198. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 199. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 200. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 201. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 204. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 205. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 206. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 207. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 208. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 209. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 210. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 211. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 212. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 213. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 214. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 215. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 216. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 217. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 218. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 219. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 220. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 221. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 222. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 223. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 224. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 225. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 226. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 228. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 229. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 230. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 231. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 232. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 233. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 234. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 235. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 236. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 237. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 246. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 247. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 248. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 249. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 250. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 251. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 252. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 253. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 254. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 255. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 256. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 257. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 258. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 259. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 260. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 261. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 262. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 263. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 264. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 265. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 266. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 267. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 268. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 269. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 270. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 271. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 272. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 273. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 274. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 275. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 276. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 277. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 278. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 279. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 280. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 281. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 282. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 283. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 284. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 285. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 286. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 287. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 288. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 289. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 290. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 291. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 292. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 293. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 294. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 295. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 296. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 297. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 298. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 299. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 300. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 301. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 302. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 303. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD MILLION)
• TABLE 304. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD MILLION)
• TABLE 305. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD MILLION)
• TABLE 306. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 307. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD MILLION)
• TABLE 308. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
• TABLE 309. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 310. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 311. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 312. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD MILLION)
• TABLE 313. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
• TABLE 314. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD MILLION)
• TABLE 315. EGYPT PATIENT BLOOD MANAGEMENT

The Patient Blood Management Market was valued at USD 15.85 billion in 2023, expected to reach USD 17.10 billion in 2024, and is projected to grow at a CAGR of 8.00%, to USD 27.17 billion by 2030.

Patient Blood Management (PBM) is a multidisciplinary, evidence-based approach to optimizing the care of patients who might need transfusion. The scope of PBM involves reducing unnecessary transfusions, minimizing blood loss, and improving patient outcomes through specific strategies tailored to individual patient needs. This approach is essential as it addresses the challenges of blood supply shortages, transfusion-related complications, and cost containment in healthcare settings. PBM is applied in various medical fields, including surgery, oncology, trauma care, and chronic disease management, with hospitals, clinics, and blood banking institutions serving as primary end-users. Market growth is influenced by the rising prevalence of chronic and surgical conditions, increasing awareness about the risks of transfusion, and advances in technologies such as cell salvage and blood substitutes. Regulatory frameworks encouraging PBM practices further spur market expansion. Opportunities in the market can be seized by investing in technologies that enhance blood conservation, automate data collection, and enable personalized medicine. The development of non-invasive hemoglobin monitoring and new erythropoiesis-stimulating agents also presents opportunities. However, challenges such as high implementation costs, lack of awareness, and reluctance to deviate from traditional transfusion practices impede market growth. Research and innovation can focus on developing cost-effective PBM solutions and educational programs to increase awareness and adoption. Analyzing patient outcomes post-PBM implementation can provide valuable data on efficacy and safety, attracting more healthcare providers to the practice. The nature of the PBM market is dynamic, propelled by technological advancements and regulatory changes. Successfully navigating this landscape requires stakeholders to stay informed on emerging trends, foster collaborations, and proactively address the challenges of blood misuse and scarcity, ensuring business growth while enhancing patient care and safety.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Patient Blood Management Market

The Patient Blood Management Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Need of blood management due to rising incidences of road accidents with the surge in the prevalence of blood disorders
  • Availability of various patient blood management guidelines
  • Government initiatives encouraging blood donations
• Market Restraints
  • High cost of the automated systems
• Market Opportunities
  • Technology advancements in the patient blood management
  • Development of advanced blood storage and blood transfusion devices
• Market Challenges
  • Shortage of medical professionals

Porter's Five Forces: A Strategic Tool for Navigating the Patient Blood Management Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Patient Blood Management Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Patient Blood Management Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Patient Blood Management Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Patient Blood Management Market

A detailed market share analysis in the Patient Blood Management Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Patient Blood Management Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Patient Blood Management Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Patient Blood Management Market

A strategic analysis of the Patient Blood Management Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Patient Blood Management Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Bio-Rad Laboratories, Inc., Biomerieux SA, Danaher Corporation, F. Hoffmann-La Roche LTD., Fresenius Se & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Immucor, Inc., LivaNova, Inc., Macopharma, Inc., Merck & Co., Inc., and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Patient Blood Management Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Accessories, Instrument, Reagent & Kit, and Software. The Accessories is further studied across Blood Bag, Syringe & Needle, and Vial & Tube. The Instrument is further studied across Blood Culture Screening Device, Blood Processing Device, Blood Storage Device, Blood Transfusion Device, and Diagnostic & Testing Instrument. The Blood Culture Screening Device is further studied across Automated Blood Culture System and Supporting Laboratory Equipment. The Blood Processing Device is further studied across Blood Cell Processor and Centrifuges. The Blood Storage Device is further studied across Medical Freezer and Medical Refrigerator. The Blood Transfusion Device is further studied across Apheresis Machine, Cell Salvage System, and Plasma & Plasma Component Separator. The Diagnostic & Testing Instrument is further studied across Blood Grouping Analyzer, Hematology Analyzer, NGS Platform, and PCR Instrument. The Reagent & Kit is further studied across Assay Kit, Blood Culture Media, Blood Typing Reagent, and Slide Staining Reagent. The Software is further studied across Blood Bank Management Software and Transfusion Management Software.
• Based on Component, market is studied across Plasma and Whole Blood & Red Blood Cell.
• Based on End User, market is studied across Blood Bank, Diagnostic Clinic & Pathology Lab, and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Need of blood management due to rising incidences of road accidents with the surge in the prevalence of blood disorders
    • 5.1.1.2. Availability of various patient blood management guidelines
    • 5.1.1.3. Government initiatives encouraging blood donations
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of the automated systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Technology advancements in the patient blood management
    • 5.1.3.2. Development of advanced blood storage and blood transfusion devices
  • 5.1.4. Challenges
    • 5.1.4.1. Shortage of medical professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Patient Blood Management Market, by Product

• 6.1. Introduction
• 6.2. Accessories
  • 6.2.1. Blood Bag
  • 6.2.2. Syringe & Needle
  • 6.2.3. Vial & Tube
• 6.3. Instrument
  • 6.3.1. Blood Culture Screening Device
    • 6.3.1.1. Automated Blood Culture System
    • 6.3.1.2. Supporting Laboratory Equipment
  • 6.3.2. Blood Processing Device
    • 6.3.2.1. Blood Cell Processor
    • 6.3.2.2. Centrifuges
  • 6.3.3. Blood Storage Device
    • 6.3.3.1. Medical Freezer
    • 6.3.3.2. Medical Refrigerator
  • 6.3.4. Blood Transfusion Device
    • 6.3.4.1. Apheresis Machine
    • 6.3.4.2. Cell Salvage System
    • 6.3.4.3. Plasma & Plasma Component Separator
  • 6.3.5. Diagnostic & Testing Instrument
    • 6.3.5.1. Blood Grouping Analyzer
    • 6.3.5.2. Hematology Analyzer
    • 6.3.5.3. NGS Platform
    • 6.3.5.4. PCR Instrument
• 6.4. Reagent & Kit
  • 6.4.1. Assay Kit
  • 6.4.2. Blood Culture Media
  • 6.4.3. Blood Typing Reagent
  • 6.4.4. Slide Staining Reagent
• 6.5. Software
  • 6.5.1. Blood Bank Management Software
  • 6.5.2. Transfusion Management Software

7. Patient Blood Management Market, by Component

• 7.1. Introduction
• 7.2. Plasma
• 7.3. Whole Blood & Red Blood Cell

8. Patient Blood Management Market, by End User

• 8.1. Introduction
• 8.2. Blood Bank
• 8.3. Diagnostic Clinic & Pathology Lab
• 8.4. Hospital

9. Americas Patient Blood Management Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Patient Blood Management Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Patient Blood Management Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Asahi Kasei Medical Co. Ltd.
• 3. B. Braun Melsungen AG
• 4. Bio-Rad Laboratories, Inc.
• 5. Biomerieux SA
• 6. Danaher Corporation
• 7. F. Hoffmann-La Roche LTD.
• 8. Fresenius Se & Co. KGaA
• 9. Grifols, S.A.
• 10. Haemonetics Corporation
• 11. Immucor, Inc.
• 12. LivaNova, Inc.
• 13. Macopharma, Inc.
• 14. Merck & Co., Inc.
• 15. Terumo Corporation